— Know what they know.
Not Investment Advice
Also trades as: PHIA.AS (AMS) · $vol 44M · PHI1.DE (XETRA) · $vol 0M · RYLPF (OTC) · $vol 0M · PHIA.DE (XETRA) · $vol 0M

PHG NYSE

Koninklijke Philips N.V.
1W: -4.1% 1M: -9.2% 3M: -15.0% YTD: -11.6% 1Y: -13.4% 3Y: +31.9% 5Y: -36.0%
$23.92
+0.11 (+0.46%)
 
Weekly Expected Move ±2.8%
$23 $23 $24 $25 $25
NYSE · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 34 · $23.4B mcap · 977M float · 0.104% daily turnover · Short 42% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 14Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 02, 2026
DCF
3
ROE
3
ROA
5
D/E
1
P/E
2
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PHG receives an overall rating of B. Strongest factors: ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5).
Rating Change History
DateFromTo
2026-10-01 B+ B
2026-08-10 B- B+
2026-07-01 B B-
2026-03-02 B- B
2026-02-12 B B-
2026-02-11 B- B
2026-01-03 B B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A
Profitability
43
Balance Sheet
56
Earnings Quality
71
Growth
55
Value
—
Momentum
84
Safety
—
Cash Flow
69

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
6/9
✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✗
Beneish M-Score
-2.63
Unlikely Manipulator
Ohlson O-Score
-8.46
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 62.3/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 2.05x
Accruals: -4.4%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PHG scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PHG's score of -2.63 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PHG's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PHG receives an estimated rating of BBB+ (score: 62.3/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). PHG's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
18.18x
PEG
0.03x
P/S
1.18x
P/B
1.78x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$17.49
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 18.2x earnings, PHG trades at a reasonable valuation. Graham's intrinsic value formula yields $17.49 per share, 37% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.754
NI / EBT
×
Interest Burden
0.812
EBT / EBIT
×
EBIT Margin
0.103
EBIT / Rev
×
Asset Turnover
0.666
Rev / Assets
×
Equity Multiplier
2.432
Assets / Equity
=
ROE
10.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PHG's ROE of 10.2% is driven by Asset Turnover (0.666), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$44.28
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with PHG's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. PHG trades at a premium to its adjusted intrinsic value of $44.28, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 18.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$23.93
Median 1Y
$21.26
5th Pctile
$11.92
95th Pctile
$38.06
Ann. Volatility
35.5%
25th–75th percentile 5th–95th percentile Median path Historical

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
65,340
+166.2% YoY
Revenue / Employee
$272,942
Rev: $17,834,000,000
Profit / Employee
$13,698
NI: $895,000,000
SGA / Employee
$76,064
Avg labor cost proxy
R&D / Employee
$26,018
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 32.9% 25.2% 23.8% 22.2% -10.1% -11.6% -15.3% -15.1% -4.5% -3.7% -6.3% -3.5% -2.7% -5.8% 3.1% 1.5% 1.5% 7.8% 8.4% 10.2% 10.21%
ROA 13.3% 11.3% 10.7% 9.6% -4.4% -5.2% -6.9% -6.5% -2.0% -1.5% -2.7% -1.4% -1.1% -2.4% 1.3% 0.6% 0.6% 3.2% 3.6% 4.2% 4.20%
ROIC 5.9% 3.7% 3.4% 2.9% -5.7% -6.2% -7.9% -7.0% 0.1% -0.5% -1.6% 1.0% 1.5% -20.7% 1.8% 1.3% 1.3% 6.7% 6.8% 7.6% 7.57%
ROCE 6.1% 3.6% 3.1% 2.5% -4.8% -6.6% -8.4% -8.1% -0.4% 1.9% 0.7% 1.1% 1.7% 0.0% 5.0% 6.0% 5.9% 7.8% 8.0% 9.4% 9.44%
Gross Margin 47.5% 39.9% 38.6% 41.5% 40.1% 41.0% 42.1% 43.9% 43.2% 35.5% 43.9% 44.6% 45.8% 38.9% 45.1% 46.4% 44.4% 44.9% 45.2% 49.3% 49.31%
Operating Margin 8.6% 3.3% -4.6% 0.3% -35.5% 3.2% -14.0% 4.9% 5.0% 0.5% -19.9% 18.3% 7.7% 3.9% 3.8% 9.2% 7.7% 10.6% 6.2% 14.0% 13.99%
Net Margin 71.5% 3.2% -3.9% -0.5% -30.9% -1.9% -15.9% 1.6% 2.0% 0.8% -24.1% 10.1% 4.1% -6.6% 1.9% 5.5% 4.3% 7.7% 3.9% 8.8% 8.81%
EBITDA Margin 12.5% 11.6% -4.5% 8.6% -32.9% 1.3% -14.0% 4.5% 4.9% 14.5% -15.6% 13.4% 8.0% 10.8% 11.3% 15.7% 14.8% 16.7% 13.8% 23.4% 23.44%
FCF Margin 11.8% 11.5% 10.5% 9.5% 8.4% 6.7% 3.7% 0.8% -2.1% -0.0% -1.0% -0.5% 3.1% 2.3% -1.6% 0.1% -1.2% 4.2% 10.8% 10.8% 10.77%
OCF Margin 14.5% 14.3% 13.2% 12.2% 11.1% 8.7% 5.7% 2.7% -0.2% 2.4% 1.7% 2.5% 5.9% 5.1% 0.6% 2.3% 0.9% 6.3% 13.0% 12.9% 12.94%
ROE 3Y Avg snapshot only 2.58%
ROE 5Y Avg snapshot only 2.22%
ROA 3Y Avg snapshot only 1.12%
ROIC 3Y Avg snapshot only 2.17%
ROIC Economic snapshot only 6.99%
Cash ROA snapshot only 8.56%
Cash ROIC snapshot only 13.35%
CROIC snapshot only 11.11%
NOPAT Margin snapshot only 7.34%
Pretax Margin snapshot only 8.36%
R&D / Revenue snapshot only 9.73%
SGA / Revenue snapshot only 27.59%
SBC / Revenue snapshot only 0.63%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 18.179
P/S Ratio — — — — — — — — — — — — — — — — — — — — 1.177
P/B Ratio — — — — — — — — — — — — — — — — — — — — 1.776
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
PEG Ratio snapshot only 0.031
Graham Number snapshot only $17.49
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.08 1.39 1.39 1.19 1.19 1.29 1.29 1.20 1.20 1.20 1.20 1.16 1.16 1.23 1.28 1.26 1.32 1.32 1.32 1.26 1.257
Quick Ratio 0.71 0.93 0.93 0.70 0.70 0.78 0.78 0.69 0.69 0.78 0.78 0.74 0.74 0.84 0.79 0.81 0.86 0.94 0.90 0.82 0.824
Debt/Equity 0.66 0.42 0.42 0.54 0.54 0.55 0.55 0.68 0.68 0.61 0.61 0.70 0.70 0.62 0.65 0.81 0.79 0.74 0.71 0.65 0.652
Net Debt/Equity 0.57 0.26 0.26 0.46 0.46 0.46 0.46 0.60 0.60 0.45 0.45 0.54 0.54 0.42 0.54 0.64 0.61 0.48 0.48 0.50 0.496
Debt/Assets 0.27 0.20 0.20 0.25 0.25 0.24 0.24 0.28 0.28 0.25 0.25 0.28 0.28 0.26 0.28 0.32 0.32 0.30 0.30 0.28 0.280
Debt/EBITDA 5.01 4.56 5.81 6.26 -12.14 -6.31 -4.67 -4.74 -86.48 12.81 14.33 9.12 7.98 8.83 3.87 4.13 3.61 3.07 2.99 2.45 2.449
Net Debt/EBITDA 4.37 2.82 3.59 5.27 -10.22 -5.30 -3.92 -4.18 -76.29 9.52 10.65 7.12 6.23 6.00 3.26 3.23 2.78 2.01 2.03 1.86 1.862
Interest Coverage 9.45 4.53 3.83 2.91 -4.90 -6.22 -6.58 -5.62 -0.29 1.39 0.54 0.81 1.20 0.01 3.06 3.57 3.82 4.34 4.58 5.00 5.003
Equity Multiplier 2.43 2.14 2.14 2.21 2.21 2.32 2.32 2.43 2.43 2.44 2.44 2.48 2.48 2.41 2.32 2.54 2.50 2.46 2.39 2.33 2.333
Cash Ratio snapshot only 0.241
Debt Service Coverage snapshot only 8.378
Cash to Debt snapshot only 0.240
FCF to Debt snapshot only 0.255
Defensive Interval snapshot only 307.6 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.64 0.58 0.59 0.56 0.56 0.58 0.59 0.59 0.60 0.60 0.60 0.61 0.61 0.62 0.64 0.64 0.64 0.64 0.65 0.67 0.666
Inventory Turnover 3.15 3.08 3.10 2.73 2.84 2.84 2.84 2.61 2.60 2.84 2.82 2.75 2.71 3.06 2.98 2.93 2.92 3.22 3.00 2.96 2.962
Receivables Turnover 5.17 4.45 4.47 5.00 5.04 4.82 4.89 5.13 5.18 4.93 4.92 4.87 4.84 4.99 5.19 5.04 5.01 4.95 5.27 5.19 5.192
Payables Turnover 5.68 4.98 5.01 5.89 6.13 5.54 5.54 6.20 6.17 5.52 5.47 6.06 5.97 5.47 5.43 5.57 5.64 5.20 5.06 4.98 4.984
DSO 71 82 82 73 72 76 75 71 70 74 74 75 75 73 70 72 73 74 69 70 70.3 days
DIO 116 118 118 134 129 129 129 140 140 128 129 133 135 119 122 125 125 113 122 123 123.2 days
DPO 64 73 73 62 60 66 66 59 59 66 67 60 61 67 67 66 65 70 72 73 73.2 days
Cash Conversion Cycle 122 127 126 145 141 138 137 152 152 136 137 148 149 125 126 131 133 117 119 120 120.3 days
Fixed Asset Turnover snapshot only 8.140
Operating Cycle snapshot only 193.5 days
Cash Velocity snapshot only 9.874
Capital Intensity snapshot only 1.512
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -4.5% -10.2% -8.2% -9.7% -4.7% 3.9% 4.8% 6.8% 6.8% 1.9% 0.4% -1.3% -2.6% -0.8% -0.9% -1.5% -1.4% -1.0% -1.9% -1.1% -1.08%
Net Income 2.3% 1.8% 1.6% 1.6% -1.4% -1.5% -1.7% -1.7% 54.8% 71.1% 62.3% 79.2% 46.1% -51.3% 1.5% 1.4% 1.5% 2.3% 1.6% 5.9% 5.88%
EPS 2.3% 1.9% 1.7% 1.8% -1.4% -1.5% -1.7% -1.6% 56.2% 71.7% 64.5% 79.1% 44.0% -52.2% 1.5% 1.4% 1.5% 2.2% 1.5% 5.8% 5.79%
FCF 27.3% 9.5% -6.1% -20.0% -32.4% -39.6% -62.9% -91.2% -1.3% -1.0% -1.3% -1.6% 2.5% 207.1% -58.6% 1.1% -1.4% 83.3% 7.7% 170.8% 170.81%
EBITDA -33.8% -19.8% -38.4% -17.0% -1.4% -1.9% -2.5% -2.4% 85.6% 1.5% 1.3% 1.5% 11.9% 48.9% 2.8% 1.3% 1.2% 2.1% 38.5% 49.3% 49.30%
Op. Income -18.4% -63.6% -70.2% -73.1% -2.3% -3.8% -5.6% -5.9% 1.0% 92.5% 81.6% 1.1% 9.7% 5.6% 5.2% 3.5% 2.1% 1.7% 0.3% 57.9% 57.89%
OCF Growth snapshot only 4.62%
Asset Growth snapshot only 1.22%
Equity Growth snapshot only 10.29%
Debt Growth snapshot only -11.41%
Shares Change snapshot only 1.24%
Dividend Growth snapshot only 18.20%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 0.7% -1.8% -2.0% -2.8% -3.2% -2.9% -2.5% -0.8% -1.0% -1.7% -1.2% -1.6% -0.3% 1.7% 1.4% 1.3% 0.8% 0.0% -0.8% -1.3% -1.30%
Revenue 5Y -5.7% -6.9% -6.9% -5.8% -4.1% -1.7% 0.4% 0.8% 0.8% 0.1% -0.2% -0.6% -1.1% -1.5% -1.6% -1.0% -1.4% -1.4% -1.2% -1.5% -1.49%
EPS 3Y 45.6% 47.9% 43.8% 33.4% — — — — — — — — — — -51.2% -63.0% — — — — —
EPS 5Y 38.1% 19.5% 15.6% 17.8% — — — — — — — — — — -18.2% -30.6% -32.2% -5.7% -4.3% -0.5% -0.54%
Net Income 3Y 43.4% 44.9% 40.5% 29.2% — — — — — — — — — — -50.8% -62.0% — — — — —
Net Income 5Y 37.1% 18.0% 13.7% 14.9% — — — — — — — — — — -18.6% -30.6% -32.0% -5.5% -4.0% -0.3% -0.28%
EBITDA 3Y -3.6% -9.1% -19.1% -17.8% — — — — — -29.9% -33.0% -16.2% -12.8% -13.8% 23.4% 16.9% — — — — —
EBITDA 5Y -10.2% -15.4% -18.5% -13.2% — — — — — -20.3% -23.7% -17.0% -15.0% -22.7% -6.5% -2.8% -0.3% 9.8% 9.9% 14.6% 14.64%
Gross Profit 3Y -1.2% -5.5% -5.7% -6.4% -7.8% -7.5% -6.3% -3.6% -3.1% -4.7% -3.1% -3.5% -2.1% 2.5% 2.5% 2.9% 3.6% 3.9% 2.3% 1.9% 1.90%
Gross Profit 5Y -4.5% -7.4% -7.6% -6.7% -6.0% -4.1% -1.9% -1.5% -1.4% -2.7% -2.8% -3.0% -3.0% -3.1% -2.9% -1.8% -2.2% -1.3% -0.7% -0.6% -0.65%
Op. Income 3Y -10.9% -31.5% -37.8% -42.2% — — — — -71.7% — — -43.1% -33.2% -1.5% 52.6% 46.0% — — — — —
Op. Income 5Y -0.5% -21.7% -26.9% -28.8% — — — — -54.4% — — -33.3% -26.8% -20.3% 0.9% -3.4% -5.7% -1.3% 1.2% 5.7% 5.72%
FCF 3Y 28.7% 25.9% 22.9% 19.5% 15.9% 2.1% -20.1% -54.2% — — — — -36.3% -40.8% — -81.1% — -14.2% 41.8% 1.4% 1.36%
FCF 5Y 19.7% 13.9% 3.1% -7.5% -9.5% -8.1% -17.4% -32.3% — — — — -9.9% -18.2% — -62.6% — -16.0% -0.1% -1.4% -1.38%
OCF 3Y 12.2% 10.0% 7.8% 5.3% 2.7% -6.6% -20.4% -38.7% — -42.9% -49.6% -43.9% -25.9% -28.0% -63.8% -42.2% -56.7% -10.2% 31.0% 66.5% 66.54%
OCF 5Y 8.2% 5.3% 0.1% -7.3% -8.8% -8.7% -16.6% -23.4% — -24.9% -29.6% -24.2% -9.6% -13.5% -44.3% -28.3% -41.5% -13.8% -1.3% -2.2% -2.16%
Assets 3Y 5.3% 6.0% 6.0% 7.2% 7.2% 4.3% 4.3% 2.4% 2.4% 2.0% 2.0% 0.5% 0.5% -2.2% -4.3% -6.7% -6.8% -4.2% -3.8% -3.3% -3.27%
Assets 5Y -1.3% -0.8% -0.6% 2.0% 1.2% 3.9% 3.9% 3.5% 3.5% 2.5% 2.5% 2.3% 2.3% 1.4% 0.1% -0.8% -0.8% -0.6% -0.3% -1.6% -1.64%
Equity 3Y 0.8% 6.1% 6.1% 7.4% 7.4% 1.7% 1.7% 3.5% 3.5% 0.4% 0.4% -0.2% -0.2% -6.0% -6.8% -11.0% -10.5% -6.1% -4.9% -1.9% -1.90%
Book Value 3Y 2.3% 8.3% 8.6% 10.8% 9.2% 3.3% 4.6% 3.8% 3.8% 1.2% 1.1% 0.3% 1.4% -5.8% -7.5% -13.3% -11.9% -7.7% -7.8% -2.7% -2.65%
Dividend 3Y -87.3% -26.3% 6.4% 54.5% 7.4% 46.3% 14.4% -5.4% -16.8% -8.0% -17.4% -32.3% -81.1% -82.2% -79.9% 35.5% 4.3% 4.6% 4.5% 5.4% 5.36%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.59 0.72 0.76 0.80 0.96 0.63 0.02 0.00 0.00 0.05 0.09 0.17 0.29 0.25 0.30 0.13 0.30 0.64 0.90 0.99 0.990
Earnings Stability 0.49 0.26 0.18 0.24 0.05 0.11 0.15 0.15 0.19 0.20 0.25 0.26 0.29 0.34 0.19 0.20 0.23 0.14 0.06 0.05 0.048
Margin Stability 0.96 0.95 0.95 0.96 0.95 0.94 0.95 0.95 0.94 0.93 0.94 0.95 0.94 0.94 0.95 0.96 0.95 0.95 0.96 0.96 0.958
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 1 0 1 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.82 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.500
Earnings Smoothness 0.00 0.05 0.10 0.11 — — — — — — — — — — — — — — 0.11 0.00 0.000
ROE Trend 0.21 0.13 0.13 0.11 -0.30 -0.29 -0.32 -0.31 -0.16 -0.09 -0.09 -0.05 0.04 0.02 0.15 0.12 0.05 0.13 0.10 0.11 0.107
Gross Margin Trend -0.01 -0.04 -0.03 -0.03 -0.05 -0.03 -0.02 -0.01 0.00 -0.00 -0.00 -0.00 0.01 0.02 0.02 0.02 0.01 0.03 0.03 0.03 0.032
FCF Margin Trend 0.05 0.04 0.02 0.00 -0.02 -0.04 -0.07 -0.09 -0.12 -0.09 -0.08 -0.06 -0.00 -0.01 -0.03 -0.00 -0.02 0.03 0.12 0.11 0.110
Sustainable Growth Rate 32.9% 24.1% 21.6% 19.0% — — — — — — — — — — 3.1% -1.2% -1.5% 4.9% 5.6% 7.0% 6.96%
Internal Growth Rate 15.4% 12.1% 10.7% 9.0% — — — — — — — — — — 1.3% — — 2.1% 2.4% 2.9% 2.95%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.70 0.74 0.73 0.71 -1.43 -0.96 -0.48 -0.24 0.05 -0.95 -0.39 -1.07 -3.27 -1.31 0.29 2.51 0.95 1.25 2.37 2.05 2.051
FCF/OCF 0.82 0.80 0.79 0.78 0.76 0.77 0.66 0.29 11.81 -0.00 -0.57 -0.20 0.52 0.45 -2.64 0.03 -1.37 0.67 0.83 0.83 0.833
FCF/Net Income snapshot only 1.708
OCF/EBITDA snapshot only 0.750
CapEx/Revenue 2.7% 2.8% 2.8% 2.8% 2.7% 2.0% 1.9% 1.9% 1.9% 2.4% 2.7% 3.0% 2.9% 2.8% 2.2% 2.2% 2.1% 2.1% 2.2% 2.2% 2.16%
CapEx/Depreciation snapshot only 0.311
Accruals Ratio 0.04 0.03 0.03 0.03 -0.11 -0.10 -0.10 -0.08 -0.02 -0.03 -0.04 -0.03 -0.05 -0.06 0.01 -0.01 0.00 -0.01 -0.05 -0.04 -0.044
Sloan Accruals snapshot only -0.045
Cash Flow Adequacy snapshot only 3.104
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 4.00%
Dividend/Share $0.00 $0.15 $0.31 $0.48 $0.62 $0.47 $0.45 $0.38 $0.34 $0.35 $0.23 $0.12 $0.00 $0.00 $0.00 $0.31 $0.34 $0.34 $0.34 $0.37 $0.85
Payout Ratio 0.0% 4.3% 9.1% 14.5% — — — — — — — — — — 0.5% 1.8% 2.0% 36.6% 33.8% 31.8% 31.78%
FCF Payout Ratio 0.0% 7.2% 15.8% 26.2% 39.1% 35.7% 58.6% 2.5% — — — — 0.4% 0.4% — 26.7% — 43.4% 17.2% 18.6% 18.60%
Total Payout Ratio 9.1% 26.6% 45.5% 66.4% — — — — — — — — — — 1.1% 3.6% 2.7% 36.6% 33.8% 37.9% 37.88%
Div. Increase Streak 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 3.27 6.52 9.20 12.86 0.84 0.93 0.97 0.99 1.43 0.88 1.08 2.07 3.86 -5.62 0.33 0.20 0.20 0.76 0.76 0.75 0.754
Interest Burden (EBT/EBIT) 0.93 0.60 0.47 0.38 1.38 1.15 1.14 1.18 4.47 -1.34 -4.82 -0.88 -0.23 31.25 1.11 0.70 0.74 0.78 0.79 0.81 0.812
EBIT Margin 0.07 0.05 0.04 0.04 -0.07 -0.08 -0.11 -0.09 -0.01 0.02 0.01 0.01 0.02 0.00 0.06 0.06 0.06 0.08 0.09 0.10 0.103
Asset Turnover 0.64 0.58 0.59 0.56 0.56 0.58 0.59 0.59 0.60 0.60 0.60 0.61 0.61 0.62 0.64 0.64 0.64 0.64 0.65 0.67 0.666
Equity Multiplier 2.47 2.23 2.23 2.31 2.31 2.23 2.23 2.31 2.31 2.38 2.38 2.46 2.46 2.43 2.38 2.51 2.49 2.44 2.36 2.43 2.432
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $3.93 $3.55 $3.41 $3.34 $-1.47 $-1.75 $-2.40 $-2.14 $-0.64 $-0.50 $-0.85 $-0.45 $-0.36 $-0.76 $0.40 $0.17 $0.17 $0.93 $1.00 $1.15 $1.15
Book Value/Share $12.48 $15.45 $15.74 $16.66 $16.04 $14.45 $15.03 $12.81 $12.80 $12.86 $12.84 $12.62 $13.02 $12.92 $12.47 $10.85 $10.95 $11.34 $11.77 $11.82 $12.01
Tangible Book/Share $-1.95 $0.16 $0.16 $-0.92 $-0.88 $-0.56 $-0.58 $-1.31 $-1.31 $-1.11 $-1.11 $-1.53 $-1.58 $-1.46 $-1.36 $-1.77 $-1.42 $-0.91 $-0.93 $-0.82 $-0.82
Revenue/Share $19.01 $18.36 $18.80 $19.45 $18.89 $19.44 $20.51 $19.41 $19.55 $19.43 $19.36 $19.25 $19.76 $19.39 $19.17 $18.66 $18.45 $18.46 $18.22 $18.24 $18.49
FCF/Share $2.25 $2.12 $1.97 $1.85 $1.59 $1.31 $0.76 $0.15 $-0.40 $-0.00 $-0.19 $-0.09 $0.61 $0.44 $-0.31 $0.01 $-0.22 $0.78 $1.97 $1.96 $1.99
OCF/Share $2.76 $2.63 $2.49 $2.38 $2.10 $1.69 $1.16 $0.52 $-0.03 $0.47 $0.34 $0.48 $1.17 $0.99 $0.12 $0.43 $0.16 $1.16 $2.37 $2.36 $2.39
Cash/Share $1.05 $2.47 $2.51 $1.43 $1.38 $1.29 $1.34 $1.02 $1.02 $2.00 $2.00 $1.93 $1.99 $2.59 $1.27 $1.91 $1.98 $2.89 $2.68 $1.85 $1.87
EBITDA/Share $1.63 $1.42 $1.13 $1.45 $-0.72 $-1.27 $-1.78 $-1.83 $-0.10 $0.61 $0.54 $0.96 $1.13 $0.91 $2.08 $2.13 $2.41 $2.73 $2.80 $3.15 $3.15
Debt/Share $8.17 $6.47 $6.59 $9.05 $8.71 $8.01 $8.33 $8.68 $8.67 $7.80 $7.78 $8.78 $9.05 $8.06 $8.07 $8.81 $8.70 $8.37 $8.37 $7.71 $7.71
Net Debt/Share $7.13 $4.00 $4.08 $7.62 $7.33 $6.72 $6.99 $7.66 $7.65 $5.80 $5.79 $6.85 $7.07 $5.47 $6.79 $6.90 $6.72 $5.48 $5.69 $5.86 $5.86
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 4 5 5 6 5 5 5 5 5 4 5 5 5 5 6 7 5 7 6 6 6
Beneish M-Score -2.36 -2.07 -2.23 -2.25 -2.76 -2.93 -2.92 -2.92 -2.62 -2.64 -2.77 -2.56 -2.66 -2.92 -2.64 -2.73 -2.66 -2.66 -2.77 -2.63 -2.634
Ohlson O-Score snapshot only -8.457
Net-Net WC snapshot only $-6.09
EVA snapshot only $-415432701.42
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB+
Credit Score 59.70 60.75 56.00 48.70 45.20 46.55 45.05 42.05 40.55 35.80 33.30 33.30 39.20 38.25 50.40 51.00 51.60 54.00 58.50 62.25 62.250
Credit Grade snapshot only 8
Credit Trend snapshot only 11.250
Implied Spread (bps) snapshot only 225.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms